Publications: Dr Jessica Okosun

Alderuccio JP, Khwaja J, Han S, Ghione P, Nizamuddin IA, Saha A, Dong N, Wang Y et al. ( 2024 ) . Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort . Blood vol. 144 , ( Supplement 1 ) 571 - 571 .

Collin M, Gagey G, Shanmugam V, Louissaint A, Okosun J, Sarkozy C, Nadel B ( 2024 ) . Follicular lymphoma research: an open dialogue for a collaborative roadmap . Histopathology

Kumar EA, Korfi K, Bewicke‐Copley F, Close K, Heward J, Witzig T, Leukam M, Ansell S et al. ( 2024 ) . CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma . British Journal of Haematology vol. 205 , ( 5 ) 1804 - 1809 .

Jamal E, Poynton E, Elbogdady M, Shamaa S, Okosun J ( 2024 ) . Prospects for liquid biopsy approaches in lymphomas . Leukemia & Lymphoma vol. ahead-of-print , ( ahead-of-print ) 1 - 11 .

Poynton E, Chernucha E, Day J, Prodger C, Hopkins D, Rakesh P, O’Neill T, Thakrar N et al. ( 2024 ) . Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis . Blood Advances . vol. 8 , 1772 - 1775 .

McIlroy G, Lax S, Gaskell C, Jackson A, Rhodes M, Seale T, Fox S, Hopkins L et al. ( 2024 ) . Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial . BMC Cancer vol. 24 , ( 1 )

Xu D, Bewicke-Copley F, Close K, Okosun J, Gale RP, Apperley J, Weinstock DM, Wendel H-G et al. ( 2024 ) . Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma . Blood Cancer Journal vol. 14 , ( 1 )

Coulter EM, Bewicke-Copley F, Mossner M, Graham TA, Fitzgibbon J, Okosun J ( 2024 ) . Defining an Optimized Workflow for Enriching and Analyzing Residual Tumor Populations Using Intracellular Markers . Journal of Molecular Diagnostics vol. 26 , ( 4 ) 245 - 256 .

Parry EM, Roulland S, Okosun J ( 2023 ) . DLBCL arising from indolent lymphomas: How are they different? . Seminars in Hematology vol. 60 , ( 5 ) 277 - 284 .

Poynton E, Chernucha E, Day J, Prodger C, Hopkins D, Rakesh P, O'Neill T, Thakrar N et al. ( 2023 ) . ABCL-184 Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis . Clinical Lymphoma Myeloma & Leukemia vol. 23 , s423 - s424 .

Okosun J ( 2023 ) . EXABS-109-LYM Should We Use Prognostic Indices and/or Biomarkers to Guide Therapy in Follicular Lymphoma? . Clinical Lymphoma Myeloma & Leukemia vol. 23 , s11 - s13 .

Poynton E, Chernucha E, Day J, Prodger C, Hopkins D, Rakesh P, O'Neill T, Thakrar N et al. ( 2023 ) . POSTER: ABCL-184 Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis . Clinical Lymphoma Myeloma & Leukemia vol. 23 ,

Linton KM, Specht L, Pavlovsky A, Thompson CA, Kimby E, de Jong D, Nastoupil LJ, Cottereau A et al. ( 2023 ) . Personalised therapy in follicular lymphoma – is the dial turning? . Hematological Oncology vol. 42 , ( 6 )

Bewicke-Copley F, Korfi K, Araf S, Hodkinson B, Kumar E, Cummin T, Ashton-Key M, Barrans S et al. ( 2023 ) . Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma . Blood Advances vol. 7 , ( 5 ) 845 - 855 .

Knight CH, Khan F, Patel A, Gill US, Okosun J, Wang J ( 2023 ) . IBRAP: integrated benchmarking single-cell RNA-sequencing analytical pipeline . Briefings in Bioinformatics vol. 24 , ( 2 )

El‐Galaly TC, Gaidzik VI, Gaman M, Antic D, Okosun J, Copland M, Sexl V, Fielding AK et al. ( 2023 ) . A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care . HemaSphere vol. 7 , ( 3 )

Perrett M, Edmondson C, Okosun J ( 2022 ) . Biology of follicular lymphoma: insights and windows of clinical opportunity . Hematology vol. 2022 , ( 1 ) 688 - 694 .

Poynton E, Chernucha E, Day J, Prodger C, Hopkins D, Rakesh P, O'Neill T, Thakrar N et al. ( 2022 ) . Impact of Double Expression of MYC and BCL-2 on Outcomes in Primary CNS Lymphoma: A UK Multicentre Analysis . Blood vol. 140 , ( Supplement 1 ) 372 - 374 .

Perrett M, Pickard L, Kumar E, Palladino G, Khan F, Edmondson C, Knight C, Poynton E et al. ( 2022 ) . Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation . Blood vol. 140 , ( Supplement 1 ) 748 - 749 .

Alcoceba M, García-Álvarez M, Okosun J, Ferrero S, Ladetto M, Fitzgibbon J, García-Sanz R ( 2022 ) . Genetics of Transformed Follicular Lymphoma . Hemato vol. 3 , ( 4 ) 615 - 633 .

Wendler J, Fox CP, Valk E, Steinheber C, Fricker H, Isbell LK, Neumaier S, Okosun J et al. ( 2022 ) . Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma . BMC Cancer vol. 22 , ( 1 )

Ngu H, Takiar R, Phillips T, Okosun J, Sehn LH ( 2022 ) . Revising the Treatment Pathways in Lymphoma: New Standards of Care-How Do We Choose? . American Society of Clinical Oncology Educational Book vol. 42 , ( 42 ) 1 - 14 .

Eyre TA, Barrington SF, Okosun J, Abamba C, Pearce RM, Lee J, Carpenter B, Crawley CR et al. ( 2022 ) . Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation . Haematologica vol. 108 , ( 3 ) 785 - 796 .

Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, Ferreri A, Morel P et al. ( 2022 ) . The EHA Research Roadmap: Malignant Lymphoid Diseases . HemaSphere vol. 6 , ( 6 )

Okosun J ( 2021 ) . Molecular Pathogenesis of Follicular Lymphoma and Its Relevance to Clinical Practice . Clinical Lymphoma Myeloma & Leukemia vol. 21 , ( Science 228 4706 1985 ) s175 - s177 .

Perrett M, Okosun J ( 2021 ) . Genetic heterogeneity in follicular lymphoma . Annals of Lymphoma vol. 5 , ( 0 ) 18 - 18 .

Wu F, Watanabe N, Tzioni M-M, Akarca A, Zhang C, Li Y, Chen Z, Cucco F et al. ( 2021 ) . Thyroid MALT lymphoma: self-harm to gain potential T-cell help . Leukemia vol. 35 , ( 12 ) 3497 - 3508 .

Poynton E, Okosun J ( 2021 ) . Liquid biopsy in lymphoma: Is it primed for clinical translation? . eJHaem vol. 2 , ( 3 ) 616 - 627 .

Heward J, Konali L, D'Avola A, Close K, Yeomans A, Philpott M, Dunford J, Rahim T et al. ( 2021 ) . KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas . Blood vol. 138 , ( 5 ) 370 - 381 .

Kumar E, Pickard L, Okosun J ( 2021 ) . Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation . British Journal of Haematology vol. 194 , ( 5 ) 810 - 821 .

Larrea E, Fernandez-Mercado M, Guerra-Assunção JA, Wang J, Goicoechea I, Gaafar A, Ceberio I, Lobo C et al. ( 2020 ) . Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma . International Journal of Molecular Sciences vol. 21 , ( 22 )

Uyulur F, Bewicke-Copley F, Anene CA, Schlesner M, Project IM-S, Siebert R, Okosun J, Fitzgibbon J et al. ( 2020 ) . Systematic Evaluation of Somatic Cis-Regulatory Mutations in Follicular Lymphoma . Blood vol. 136 , ( Supplement 1 ) 26 - 27 .

Okosun J ( 2020 ) . Abstract IA38: Defining lymphoma reservoirs: Clues from the genomics . Blood Cancer Discovery vol. 1 , ( 3_Supplement ) ia38 - ia38 .

Pickard L, Palladino G, Okosun J ( 2020 ) . Follicular lymphoma genomics . Leukemia & Lymphoma vol. 61 , ( 10 ) 2313 - 2323 .

Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V et al. ( 2020 ) . Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients . British Journal of Haematology

Kumar EA, Okosun J, Fitzgibbon J ( 2020 ) . The Biological Basis of Histologic Transformation . Hematology/Oncology Clinics of North America vol. 34 , ( 4 ) 771 - 784 .

Okosun J, Montoto S ( 2020 ) . Cellular Therapy in Follicular Lymphoma Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, and Chimeric Antigen Receptor T-cell Therapy . Hematology/Oncology Clinics of North America vol. 34 , ( 4 ) 701 - 714 .

Araf S, Korfi K, Bewicke-Copley F, Wang J, Cogliatti S, Kumar E, Forrer F, Barrington SF et al. ( 2020 ) . Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma . Haematologica vol. 105 , ( 6 ) 318 - 321 .

Krysov S, Odabashian M, Carlotti E, Araf S, Okosun J, Spada F, Gribben J, Forconi F et al. ( 2020 ) . IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution . Blood vol. 135 , ( 11 ) 834 - 844 .

Bewicke-Copley F, Korfi K, Araf S, Kumar EA, Cummin TEC, Ashton-Key M, Barrans S, Van Hoppe S et al. ( 2019 ) . Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel . Blood vol. 134 , ( Supplement_1 )

Ortega-Molina A, Deleyto-Seldas N, Carreras J, Sanz A, Lebrero-Fernández C, Menéndez C, Vandenberg A, Fernández-Ruiz B et al. ( 2019 ) . Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR . Nature Metabolism vol. 1 , ( 8 ) 775 - 789 .

Matasar MJ, Luminari S, Barr PM, Barta SK, Danilov AV, Hill BT, Phillips TJ, Jerkeman M et al. ( 2019 ) . Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs . The Oncologist vol. 24 , ( 11 ) e1236 - e1250 .

Kumar E, Okosun J ( 2019 ) . Follicular lymphoma genomics . HemaSphere vol. 3 , ( Suppl ) 79 - 81 .

Kumar E, Korfi K, Bewicke‐Copley F, Witzig T, Leukam M, Ansell S, Scott J, Rallis K et al. ( 2019 ) . PF513 MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA . HemaSphere vol. 3 , ( S1 )

Bödör C, Batlevi C, Nagy N, Michot J, Schneider T, Alizadeh H, Simon Z, Vose J et al. ( 2019 ) . PS1247 EZH2 GAIN‐OF‐FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A PRELIMINARY ANALYSIS ON 590 PATIENTS . HemaSphere vol. 3 , ( S1 ) 568 - 569 .

Heward J, Koniali L, D’Avola A, Close K, Yeomans A, Johnson P, Okosun J, Neve R et al. ( 2019 ) . S844 KDM5 INHIBITION OFFERS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF KMT2D MUTANT LYMPHOMAS . HemaSphere vol. 3 , ( S1 ) 376 - 377 .

Okosun J, Bödör C, Batlevi C, Nagy N, Michot J, Schneider T, Alizadeh H, Simon Z et al. ( 2019 ) . EZH2 GAIN‐OF‐FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL): A PRELIMINARY ANALYSIS ON 590 PATIENTS . Hematological Oncology vol. 37 , ( S2 ) 192 - 193 .

Korfi K, Araf S, Bewicke‐Copley F, Kumar E, Cummin T, Ashton‐Key M, Barrans S, Van Hoppe S et al. ( 2019 ) . LONGITUDINAL ANALYSES OF DIAGNOSTIC‐RELAPSE BIOPSIES OF DIFFUSE LARGE B CELL LYMPHOMA SUGGEST THAT RELAPSE IS MEDIATED BY DISTINCT MECHANISMS IN ABC AND GCB LYMPHOMA . Hematological Oncology vol. 37 , ( S2 ) 142 - 143 .

Pettitt AR, Barrington S, Kalakonda N, Khan UT, Jackson R, Carruthers S, Oates M, Lin K et al. ( 2019 ) . NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA . Hematological Oncology vol. 37 , ( S2 ) 67 - 68 .

Kumar E, Korfi K, Bewicke-Copley F, Witzig T, Leukam M, Ansell S, Scott J, Rallis K et al. ( 2019 ) . MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA . HemaSphere vol. 3 ,

Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V et al. ( 2019 ) . Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant . Haematologica vol. 104 , ( 4 ) e174 - e177 .

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al. ( 2019 ) . Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma . Leukemia vol. 33 , ( 6 ) 1540 - 1540 .

Odabashian M, Carlotti E, Araf S, Okosun J, Forconi F, Stevenson FK, Gribben JG, Calaminici M et al. ( 2018 ) . Immunoglobulin Variable Region Gene Sequences Reveal N-Glycosylation Motifs As an Early and Stable Event in Follicular Lymphoma Pathology . Blood . Conference: Search Results Web results ASH Meeting on Lymphoma Biology vol. 132 , 4101 - 4101 .

Okosun J, Kridel R, Fitzgibbon J ( 2018 ) . Rituximab as a first step in tackling transformation . The Lancet Haematology vol. 5 , ( 8 ) e326 - e327 .

Heward JA, Kumar EA, Korfi K, Okosun J, Fitzgibbon J ( 2018 ) . Precision medicine and lymphoma . Curr Opin Hematol vol. 25 , ( 4 ) 329 - 334 .

Araf S, Okosun J, Fitzgibbon J ( 2018 ) . Predicting early relapse in follicular lymphoma: have we turned a corner? . The Lancet Oncology vol. 19 , ( 4 ) 441 - 442 .

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward J et al. ( 2018 ) . Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma . Leukemia vol. 32 , ( 5 ) 1261 - 1265 .

Horton SJ, Giotopoulos G, Yun H, Vohra S, Sheppard O, Bashford-Rogers R, Rashid M, Clipson A et al. ( 2017 ) . Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors . Nature Cell Biology . vol. 19 , 1093 - 1104 .

Araf S, Wang J, Korfi K, Pangault C, Kotsiou E, Rio-Machin A, Rahim T, Heward JA et al. ( 2017 ) . Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma . BLOOD . vol. 130 ,

Araf S, Korfi K, Nagano A, Cummin TEC, Bentley M, Thorner AR, Ashton-Key M, Calaminici M et al. ( 2017 ) . Longitudinal Analyses of the Genomic, Transcriptomic, and T Cell Repertoire in Diffuse Large B Cell Lymphoma Demonstrates Changes in Signaling and Immune Recognition at Relapse . BLOOD . vol. 130 ,

Larrea E, Fernandez-Mercado M, Ceberio I, Assuncao JAG, Okosun J, Fitzgibbon J, Lawrie C ( 2017 ) . RECURRENT MUTATIONS IN MICRO-RNA BINDING SITES MAY BE POTENTIALLY RELEVANT IN FOLLICULAR LYMPHOMA . HAEMATOLOGICA . vol. 102 , 94 - 95 .

Noerenberg D, Mansouri L, Young E, Mareike F, Abdulla M, Asmar F, Gonzalez-Farre B, Anna T et al. ( 2016 ) . ΝFΚΒΙΕ Deletions: A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma . Blood vol. 128 , ( 22 )

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V et al. ( 2016 ) . Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma . Blood vol. 128 , ( 23 ) 2666 - 2670 .

Larrea E, Fernandez-Mercado M, Ceberio I, Guerra-Assunção JA, Okosun J, Fitzgibbon J, Lawrie C ( 2016 ) . 110 Follicular lymphoma cases harbour recurrent mutations in micro-RNA binding sites of genes associated with lymphomagenesis . European Journal of Cancer vol. 61 , s11 - s12 .

Okosun J, Montoto S, Fitzgibbon J ( 2016 ) . The routes for transformation of follicular lymphoma . Current Opinion in Hematology vol. 23 , ( 4 ) 1 - 1 .

Kotsiou E, Okosun J, Besley C, Iqbal S, Matthews J, Fitzgibbon J, Gribben J, DAVIES JK ( 2016 ) . TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses . Blood vol. 128 , ( 1 ) 72 - 81 .

Okosun J, Fitzgibbon J ( 2016 ) . 5. Follicular lymphoma . Malignant Lymphomas , De Gruyter

Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF et al. ( 2016 ) . Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma . Nature Genetics vol. 48 , ( 2 ) 183 - 188 .

Okosun J, Fitzgibbon J ( 2016 ) . Follicular lymphoma . Malignant Lymphomas: Biology and Molecular Pathogenesis ,

Larrea E, Fernandez-Mercado M, Ceberio I, Guerra-Assuncao JA, Okosun J, Fitzgibbon J, Lawrie C ( 2016 ) . Follicular lymphoma cases harbour recurrent mutations in microRNA binding sites of genes associated with lymphomagenesis . EUROPEAN JOURNAL OF CANCER . vol. 61 , S11 - S12 .

Araf S, Wang J, Pangault C, Kotsiou E, Hoxha E, Iqbal S, Davies J, Johnson P et al. ( 2016 ) . GENOMIC PROFILING REVEALS SPATIAL HETEROGENEITY IN FOLLICULAR LYMPHOMA: IMPLICATIONS FOR PRECISION MEDICINE . HAEMATOLOGICA . vol. 101 , 270 - 270 .

Araf S, Okosun J, Koniali L, Fitzgibbon J, Heward J ( 2015 ) . Epigenetic dysregulation in follicular lymphoma . Epigenomics vol. 8 , ( 1 ) 77 - 84 .

Okosun J, Cwynarski K ( 2015 ) . Non‐Hodgkin Lymphoma: High Grade . Postgraduate Haematology , Wiley

Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C, Savic A, Van Delft FW et al. ( 2015 ) . Disease evolution and outcomes in familial AML with germline CEBPA mutations . Blood vol. 126 , ( 10 ) 1214 - 1223 .

Okosun J, Packham G, Fitzgibbon J ( 2014 ) . Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies . Expert Opinion on Investigational Drugs vol. 23 , ( 10 ) 1321 - 1332 .

Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D et al. ( 2014 ) . Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma . Nature Genetics vol. 46 , ( 2 ) 176 - 181 .

Popov N, Maniati E, Marzec J, Okosun J, Scott R, Kranz A, Stewart F, Chelala C et al. ( 2013 ) . Investigating The Role Of MLL2 (Mll4) In B Cell Development . Blood . vol. 122 ,

Bödör C, Grossmann V, Popov N, Okosun J, O’Riain C, Tan K, Marzec J, Araf S et al. ( 2013 ) . EZH2 mutations are frequent and represent an early event in follicular lymphoma . Blood vol. 122 , ( 18 ) 3165 - 3168 .

Okosun J, Bödör C, Wang J, Araf S, Chelala C, Fitzgibbon J ( 2013 ) . Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies . Clinical Epigenetics vol. 5 , ( Suppl 1 )

Okosun J, Clear A, Iqbal S, Matthews J, Gribben J, Fitzgibbon J, Davies J ( 2013 ) . TNFRSF14 aberrations are associated with death from acute GvHD after reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation for follicular lymphoma . BONE MARROW TRANSPLANTATION . vol. 48 , S169 - S169 .

Böodöor C, Vera G, Kohlmann A, Tan K, Okosun J, Popov N, Araf S, Marzec J et al. ( 2012 ) . High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy . Blood vol. 120 , ( 21 )

Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al. ( 2012 ) . HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era . Journal of Clinical Oncology vol. 30 , ( 33 ) 4111 - 4116 .

Okosun J, Warbey V, Shaw K, Montoto S, Fields P, Marcus R, Virchis A, McNamara C et al. ( 2012 ) . Interim fluoro-2-deoxy-D-glucose–PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection . AIDS vol. 26 , ( 7 ) 861 - 865 .

Orkin C, Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M et al. ( 2012 ) . HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era . HIV MEDICINE vol. 13 , 5 - 5 .

Okosun J, Bödör C, Smith M ( 2011 ) . Myelodysplastic syndrome: 2011 and beyond . British Journal of Nursing vol. 20 , ( 22 ) 1434 - 1434 .

Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al. ( 2011 ) . HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era, . Blood vol. 118 , ( 21 )

Okosun J, Fitzgibbon J ( 2011 ) . It's a targeted world in non-Hodgkin's lymphoma . British Journal of Nursing vol. 20 , ( 17 SUPPL. )

Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K et al. ( 2011 ) . HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era . BLOOD . vol. 118 , 1557 - 1557 .

Okosun J, Mwirigi A, Kyriakou C, Cwynarski K, Hughes D, Fields P, Mcnamara C ( 2011 ) . PROGNOSTIC SIGNIFICANCE OF RESPONSE QUALITY (RQ) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL) PATIENTS TREATED WITH COMBINATION RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISOLONE (R-CVP) . ANNALS OF ONCOLOGY . vol. 22 , 218 - 218 .

Okosun J, McNamara C ( 2010 ) . Paraneoplastic peripheral blood eosinophilia in relapsed follicular lymphoma . Leukemia & Lymphoma vol. 52 , ( 2 ) 328 - 330 .

Bower M, Montoto S, Cwynarski K, Lumsden AS, Rajab R, Okosun J, Orkin C, Nelson M et al. ( 2010 ) . Non-germinal centre subtype of AIDS-related diffuse large B-cell lymphomas associated with improved survival . HIV MEDICINE vol. 11 , 13 - 13 .